# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Cadisegliatin is a potential first-in-class oral liver selective glucokinase activator for T1D, which has been granted Breakthr...
Cantex Pharmaceuticals, Inc., a clinical-stage pharmaceutical company focused on developing transformative therapies for cance...
vTv Therapeutics (NASDAQ:VTVT) reported quarterly losses of $(1.17) per share. This is a 51.25 percent increase over losses of ...
vTv Therapeutics (NASDAQ:VTVT) reported quarterly losses of $(1.67) per share. This is a 26.75 percent increase over losses of ...
U.S. stocks traded lower toward the end of trading, with the Dow Jones index falling around 100 points on Wednesday. The Dow t...
Shares of Bumble Inc. (NASDAQ: BMBL) fell sharply during Wednesday’s session following weak quarterly results.